Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Medical Laboratory Specialist

Laboratory Medicine · Syria · 2025-08-06

Processing Time
608 days
Decision Date
2025-08-06
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in laboratory medicine focusing on the mechanisms of complex medical conditions, including autoimmune and vascular disorders. The work involves investigating specific antibodies and proteins to improve diagnostic accuracy and identify new therapeutic targets. This endeavor aims to reduce misdiagnoses and enable more effective clinical treatments for chronic and rare diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses mechanisms of complex medical conditions, directly benefiting healthcare systems by reducing misdiagnoses.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, 17 publications, and 438 citations demonstrate a history of impactful research and peer recognition.

3 Balance of Interests Met

The petitioner's unique expertise in rare disease diagnostics makes it beneficial for the U.S. to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 17 peer-reviewed publications and 438 citations, including papers ranked among the most highly cited in clinical medicine. Evidence included active service as a peer reviewer and letters from independent experts confirming the reproducibility and clinical relevance of the work. All three Dhanasar prongs were satisfied despite an initial RFE.

Request for Evidence (RFE)

Successfully Addressed

The RFE challenged the national importance and the petitioner's positioning; the response utilized the client's strong publication and citation record to secure approval.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the Endeavor

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
323 days 2025-06-16
The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
93 days 2023-03-03
The petitioner proposes to refine diagnostic and therapeutic strategies for complex and chronic diseases by integrating molecular profiling, cellular modeling, and translational biomedical analysis. His work leverages multi-omics data and advanced bioanalysis to deepen the mechanistic understanding of disease progression and treatment response. The endeavor aims to translate biological discoveries into actionable improvements in precision medicine and clinical outcomes.
View Case

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Scientist

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
California 290 days 2025-02-18
The petitioner proposes to develop optimized in vitro diagnostic tools to provide preventative healthcare solutions and treatment strategies for cancer and infectious diseases. The work involves utilizing advanced molecular and cellular techniques to improve the accuracy, sensitivity, and specificity of diagnostic assays. This endeavor aims to improve early disease detection and reduce the management burden within the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Syria

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-06.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 608 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Syria All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist